 |
PDBsum entry 1vig
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Ribonucleoprotein
|
PDB id
|
|
|
|
1vig
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Three-Dimensional structure and stability of the kh domain: molecular insights into the fragile X syndrome.
|
 |
|
Authors
|
 |
G.Musco,
G.Stier,
C.Joseph,
M.A.Castiglione morelli,
M.Nilges,
T.J.Gibson,
A.Pastore.
|
 |
|
Ref.
|
 |
Cell, 1996,
85,
237-245.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
Note In the PDB file this reference is
annotated as "TO BE PUBLISHED".
The citation details given above were identified by an automated
search of PubMed on title and author
names, giving a
percentage match of
96%.
|
 |
 |
|
Abstract
|
 |
|
The KH module is a sequence motif found in a number of proteins that are known
to be in close association with RNA. Experimental evidence suggests a direct
involvement of KH in RNA binding. The human FMR1 protein, which has two KH
domains, is associated with fragile X syndrome, the most common inherited cause
of mental retardation. Here we present the three-dimensional solution structure
of the KH module. The domain consists of a stable beta alpha alpha beta beta
alpha fold. On the basis of our results, we suggest a potential surface for RNA
binding centered on the loop between the first two helices. Substitution of a
well-conserved hydrophobic residue located on the second helix destroys the KH
fold; a mutation of this position in FMR1 leads to an aggravated fragile X
phenotype.
|
 |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Suggested Surface for RNA RecognitionMOLSCRIPT
representation of the Vig-6 domain, showing conserved positive
charges (light blue) and the backbone of the GkxG loop (yellow).
|
 |
Figure 5.
Figure 5. Models of the Two KH Repeats of FMR1Models are
based on the coordinates of the Vig-6 average structure and the
new sequence alignment (Figure 3). Coloring is as follows:
magenta, the backbone atoms; green, the hydrophobic side chains;
yellow, the position affected by the mutation (isoleucine to
asparagine) at residues Ile-241 and Ile-304) of the FMR1 protein.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Cell
(1996,
85,
237-245)
copyright 1996.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
The kh module has an alpha beta fold.
|
 |
|
Authors
|
 |
M.A.Castiglone morelli,
G.Stier,
T.Gibson,
C.Joseph,
G.Musco,
A.Pastore,
G.Travè.
|
 |
|
Ref.
|
 |
Febs Lett, 1995,
358,
193-198.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Schematic representation of the vigilin architecture: ovals indi-
cate the KH motifs, linkes represent putative s-helical regions [10]. The
five constructs expressed are indicated below. Numbers on the con-
structs refer to the corresponing amino acid positions in te complete
vigilin sequence from human. For simplicity the numbering adopted in
the text refers to the starting of construct III so that for nstance Asn-7
coresponds to Asn-434 of the complete sequence. The sequence of
construct I is explicitly shown: the sequence of the KH module is
indicated in roman letters, while those of the flanking putative helices
ar in italics.
|
 |
Figure 3.
Fig. 3. (a) Survey o the NOE effects observed. In italics is the secondary
structure prediction as obtained from the PredictProtein EMBL e-mail
server [23] is reported together with the degree of confidence. The main
classes of shor range contacts observed are shown togethe with the
secondary chemical shifts (SCS) and protons which are solvent inacces-
sible in solvent saturation transfer experiments (UP). A window of + 2
points as used to smooth the SCS data. (b) The three-strandedfl-sheet
of the KH. Continuous lines identify observed nterstrand NOEs. A
dotted line between Ile-14 and Ile-55 indicates that this effect could not
be observed because these two amides are coincident. (c) Schematic
reresentation of te secondary structure of the KH domain n the same
orientation s in b.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the Federation of European Biochemical Societies
|
 |
|
|
|
|
 |